Endocrine complications of hematopoietic stem cell transplantation

Endocrinol Metab Clin North Am. 2007 Dec;36(4):983-98; ix. doi: 10.1016/j.ecl.2007.07.002.

Abstract

Advances in hematopoietic stem cell transplantation (HSCT) have resulted in broader indications for this therapeutic modality in both malignant diseases and nonmalignant conditions. This article focuses on the late endocrine abnormalities that are most commonly observed following successful HSCT, with a special emphasis on pediatric HSCT recipients, for whom long-term follow-up data are increasingly available.

Publication types

  • Review

MeSH terms

  • Bone Density
  • Endocrine System Diseases / etiology*
  • Female
  • Glucose / metabolism
  • Gonadotropins / deficiency
  • Growth Disorders / etiology
  • Growth Hormone / deficiency
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Male
  • Reproduction
  • Thyroid Diseases / etiology
  • Thyrotropin / deficiency
  • Transplantation Conditioning / adverse effects
  • Whole-Body Irradiation / adverse effects

Substances

  • Gonadotropins
  • Thyrotropin
  • Growth Hormone
  • Glucose